| 1 |
中国抗癌协会血液肿瘤专业委员会，中华医学会血液学分会白血病淋巴瘤学组. 原发性轻链型淀粉样变的诊断和治疗中国专家共识(2016)[J]. 中华血液学杂志, 2016,37(9):742-746.
|
| 2 |
Mikhael JR, Schuster SR, Jimenez-Zepeda VH, et al. Cyclophosphamide-bortezomib-dexamethasone(CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis[J]. Blood, 2012,119(19):4391-4394.
|
| 3 |
Palladini G, Perfetti V, Obici L, et al. Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL amyloidosis who are ineligible for stem cell transplantation[J]. Blood, 2004,103(8):2936-2938.
|
| 4 |
Palladini G, Russo P, Nuvolone M, et al. Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis[J]. Blood, 2007,110(2):787-788.
|
| 5 |
Jaccard A, Moreau P, Leblond V, et al. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis[J]. N Engl J Med, 2007,357(11):1083-1093.
|
| 6 |
Dispenzieri A, Lacy MQ, Zeldenrust SR, et al. The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis[J]. Blood, 2007,109(2):465-470.
|
| 7 |
Sanchorawala V, Wright DG, Rosenzweig M, et al. Lenalidomide and dexamethasone in the treatment of AL amyloidosis:results of a phase 2 trail[J]. Blood, 2007,109(2):492-496.
|
| 8 |
Sanchorawala V, Finn KT, Fennessey S, et al. Durable hematologic complete rseponses can be achieved with lenalidomide in AL amyloidosis[J]. Blood, 2010,116(11):1990-1991.
|
| 9 |
Dispenzieri A, Lacy M, Zeldenrust S, et al. Long term follow-up of patients with immunoglobulin light chain amyloidosis treated with lenalidomide and dexamethasone[J]. Blood, 2008,112(11):1737.
|
| 10 |
Kumar SK, Hayman SR, Buadi FK, et al. Lenalidomide, cyclophosphamide, and dexamethasone for light-chain amyloidosis: long-term results from a phase 2 trial[J]. Blood, 2012,119(21):4860-4867.
|
| 11 |
Dispenzieri A, Buadi F, Laumann K, et al. Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis[J]. Blood, 2012,119(23):5397-5404.
|
| 12 |
Kastritis E, Anagnostopoulos A, Roussou M, et al. Treatment of light chain amyloidosis with the combination of bortezomib and dexamethasone[J]. Haematologica, 2007,92(10):1351-1358.
|
| 13 |
Zonder J, Sanchorawala V, Snyder R, et al. Rapid haematologic and organ responses in patients with AL amyloid treated with bortezomib plus melphalan and dexamethason[J]. Amyloid, 2010,17(s1):86.
|